Skip to content
Home/Companies/Pharma/Cambrex
Cambrex

Cambrex

Pharma·US·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Cambrex?

Cambrex is currently owned by Permira through Permira VII (2019 vintage), since 2019.

Hand-verified · updated 2026-04-21

Permira
Investor
Permira
Permira VII · 2019 · Buyout

Key facts

HQUSA
SectorPharma
Websitewww.cambrex.com

More from Permira VII

Other portfolio companies in the same fund.

Kedrion
Active
PharmaItaly· 2022
McAfee
McAfee
Active
CybersecurityUS· 2022
Mimecast
Mimecast
Active
CybersecurityUK· 2022
Boats Group
Active
E-commerceUS· 2021
Golden Goose
Golden Goose
Exited 2025
ConsumerItaly· 2020
to
Lytx
Lytx
Active
AI/MLUS· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Cambrex

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cambrex?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cambrex.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue